PATHOLOGICAL DESCRIPTION OF NATIVE LIVER IN HIV-HCV COINFECTED PATIENTS TRANSPLANTED FOR HEPATOCELLULAR CARCINOMA - A COMPARATIVE STUDY WITH HCV MONOINFECTED PATIENTS

被引:0
|
作者
Vibert, E.
Ghigna, M. R.
Adam, R.
Azoulay, D.
Castaing, D.
Samuel, D.
Guettier, C.
Duclos-Vallee, J. C.
机构
[1] Hop Paul Brousse, AP HP, Ctr Hepato Biliaire, Villejuif, France
[2] Hop Bicetre, AP HP, Dept Pathol, Villejuif, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S196 / S196
页数:1
相关论文
共 50 条
  • [21] Occult hepatitis B in HIV-HCV coinfected patients
    Piroth, Lionel
    Lafon, Marie-Edith
    Binquet, Christine
    Bertillon, Pascale
    Gervais, Anne
    Lootvoet, Enguerrand
    Lang, Jean-Marie
    De Jaureguiberry, Jean Pierre
    Chene, Genevieve
    Leport, Catherine
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (10) : 835 - 839
  • [22] Chronic hepatitis C in HIV-HCV coinfected patients
    Gervais, A
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 : B121 - B132
  • [23] Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV–HCV coinfected patients, irrespective of liver disease severity
    Thijs Feuth
    Debbie Van Baarle
    Andy I. M. Hoepelman
    Karel J. Van Erpecum
    Peter D. Siersema
    Joop E. Arends
    Apoptosis, 2014, 19 : 1128 - 1135
  • [24] HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients
    Duclos-Vallee, JC
    Vittecoq, D
    Teicher, E
    Feray, C
    Roque-Afonso, AM
    Lombes, A
    Jardel, C
    Gigou, M
    Dussaix, E
    Guettier, C
    Sebagh, M
    Azoulay, D
    Adam, R
    Ichai, P
    Saliba, F
    Roche, B
    Castaing, D
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2004, 40 : 44 - 44
  • [25] Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV coinfected patients
    Milazzo, L.
    Meroni, L.
    Galazzi, M.
    Cesari, M.
    Caramma, I.
    Marchetti, G.
    Galli, M.
    Antinori, S.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (07) : 479 - 484
  • [26] Liver transplantation for HCV cirrhosis in HIV-HCV coinfected patients. Evaluation of antiretroviral toxicity and of HCV recurrence.
    Samuel, D
    Vittecoq, D
    Duclos-Vallee, JC
    Feray, C
    Teicher, E
    Azoulay, D
    Saliba, F
    Afonso, AMR
    Ichai, P
    Castaing, D
    Adam, R
    Guettier, C
    Dussaix, E
    Bismuth, H
    HEPATOLOGY, 2002, 36 (04) : 231A - 231A
  • [27] PREDICTORS OF LIVER FIBROSIS PROGRESSION AND ACCESS TO HCV TREATMENT IN A FRENCH UNIT OF HIV-HCV COINFECTED PATIENTS
    Dominguez, Stephanie
    Levy, Yves
    Chevaliez, Stephane
    Pawlotsky, Jean-Michel
    Roudot-Thoraval, Francoise
    HEPATOLOGY, 2011, 54 : 834A - 834A
  • [28] Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases
    Maida, Ivana
    Soriano, Vincent
    Barreiro, Pablo
    Rivas, Pablo
    Labarga, Pablo
    Nunez, Marina
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (06) : 801 - 804
  • [29] Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemia
    Diakite, M.
    Hartig-Lavie, K.
    Miailhes, P.
    Pradat, P.
    Uhres, A. -C.
    Zoulim, F.
    Sarda, M. -N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S528 - S529
  • [30] HIV-HCV coinfected patients, followed prospectively for a mean of 4.2 years, have similar rates of death or cirrhosis compared to HCV monoinfected patients.
    Monto, A
    Dove, LM
    Seal, KH
    Miller, E
    Lebel, A
    Shen, H
    Tracy, D
    Wright, TL
    HEPATOLOGY, 2004, 40 (04) : 692A - 693A